SLC25A11 and hepatocellular carcinoma: Pan et al. found that SLC25A11 was downregulated in HCC compared to normal controls, and low expression of SLC25A11 was significantly associated with the clinical stage, vital status, histologic grade, overall survival (OS), and relapse-free survival (RFS).